Related Experiment Videos

Paediatric antibiotic prescribing by general dental practitioners in England

N O Palmer1, M V Martin, R Pealing

  • 1Department of Clinical Dental Sciences, University of Liverpool, UK.

Insights

General dental practitioners in England often prescribe liquid antibiotics for children inappropriately. This practice, including incorrect dosages and durations, may worsen antimicrobial resistance. Clearer guidelines and education are needed for these healthcare providers.

Area of Science:

  • Pharmacology
  • Public Health
  • Pediatric Medicine

Background:

  • Inappropriate antibiotic use is a significant driver of antimicrobial resistance.
  • There is a lack of data on antibiotic prescribing patterns for pediatric patients by dental practitioners.
  • This study addresses the gap by examining liquid antibiotic prescriptions for children in England.

Purpose of the Study:

  • To investigate the prescribing patterns of liquid-based antibiotics for children by general dental practitioners (GDPs) in England.
  • To identify variations in antibiotic choice, dosage, frequency, duration, and sugar content.
  • To assess potential contributions to antimicrobial resistance.

Main Methods:

  • Analysis of National Health Service (NHS) liquid-based prescriptions issued by GDPs in England.
  • Inclusion of all prescriptions from 10 Health Authorities for February 1999.
  • Detailed examination of pediatric liquid antibiotic prescriptions, including antibiotic type, sugar-free status, dose, frequency, and duration.

Main Results:

  • Out of 18,614 antibiotic prescriptions, 1609 were liquid-based for children.
  • Amoxicillin (75.5%) and phenoxymethylpenicillin (15.2%) were the most common antibiotics.
  • Significant variations in dosage, frequency, and duration were observed, with many prescriptions deviating from manufacturer recommendations. Only 29.1% were sugar-free.

Conclusions:

  • Some GDPs prescribe liquid antibiotics for children inappropriately.
  • These prescribing practices may exacerbate the issue of antimicrobial resistance.
  • Development of clear guidelines and educational programs for GDPs is recommended to improve prescribing habits.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...